ClinicalTrials.gov
public full text
Public Domain
Objective Markers and New Indicators in AI Disease (OMNI-AID Study)
This pilot study is designed to compare healthy volunteers with three groups of patients with adrenal insufficiency and a final group of patients receiving high dose steroids for anti-inflammatory purposes. The study will collect data on all 5 groups with the intention of identifying any novel markers or immunological indicators which may be used clinically to gauge the adequacy of steroid replacement treatment in patients with adrenal insufficiency.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.#980605
- Disease Progression in Women With X-linked Adrenoleukodystrophy#854595
- Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients#462445
- An Investigation of a Multi-Function Skincare Product to Improve Aging, Eczema, and Acne Outcomes#1127455
- Workplace size and cardiovascular disease subtypes among 11 million Korean wage workers: a nationwide cross-sectional study.#1167297
Record · ID 1171405
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive